CN101366897A - A Chinese medicinal capsule for treating hepatitis B - Google Patents
A Chinese medicinal capsule for treating hepatitis B Download PDFInfo
- Publication number
- CN101366897A CN101366897A CNA2008101072567A CN200810107256A CN101366897A CN 101366897 A CN101366897 A CN 101366897A CN A2008101072567 A CNA2008101072567 A CN A2008101072567A CN 200810107256 A CN200810107256 A CN 200810107256A CN 101366897 A CN101366897 A CN 101366897A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicinal
- medicinal capsule
- treatment
- treating hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 7
- 208000002672 hepatitis B Diseases 0.000 title claims description 7
- 241000628997 Flos Species 0.000 claims description 10
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 208000006454 hepatitis Diseases 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 241001660870 Cyrtomium Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal capsule for treating hepatitis, which comprises the following ingredients: 7 g of wild chrysanthemum flower, 3 g of heartleaf houttuynia herb, 7 g of honeysuckle flower, 3 g of dahurian patrinia herb, 3 g of paris rhizome, 5 g of salvia miltiorrhiza, 5 g of cyrtomium rhizome and 1 g of dried toad skin. The traditional Chinese medicine composition is convenient to take, free of toxic and side effects, good in curative effect and short in treatment course, and clinical treatment conditions of thousands of patients show that the effective rate is 85% and the radical treatment rate is more than 80%.
Description
Technical field
The present invention relates to a kind of Chinese medicinal capsule for the treatment of hepatitis B, belong to the technical field of pharmaceuticals for the treatment of disease.
Background technology
Hepatopathy is to be stranded the persistent ailment of scratching people, and in the medicine of treatment acute, chronic hepatitis commonly used, all kinds of Chinese medicine and western medicine are of a great variety, but mostly based on alt-reducing and liver-protecting, though certain curative effect is arranged, in the human body immunity improving function, impel body to produce antibody, the effect deficiency of inhibition virus replication etc.
Summary of the invention
Order of the present invention just is to provide a kind of energy human body immunity improving function, impels body to produce effects such as antibody, inhibition virus replication, hepatopathy is had the hepatitis B Chinese medicinal capsule of good therapeutic effect.
Purpose of the present invention can realize by following measure:
Prescription of the present invention is: Flos Chrysanthemi Indici 6
-8 grams, Herba Houttuyniae 2
-4 grams, Flos Lonicerae 6
-8 grams, Herba Patriniae 2
-4 grams, Rhizoma Paridis 2
-4 grams, Radix Salviae Miltiorrhizae 4
-6 grams, Rhizoma Osmundae 4
-6 grams, dry maxima skin 1-1.3 gram.
The invention has the advantages that: the curative effect height, do not have return jumpings, have no side effect, cost is low, do not recur after healing, can effectively improve liver function and suppress hepatitis B replication, impel HBV, e antigen to turn out cloudy, reach the clinical cure purpose, effective percentage of the present invention can reach 85%, cure rate is up to 80%, and relapse rate is low, is worth clinical expansion.
The specific embodiment
Embodiment one, and prescription of the present invention is: Flos Chrysanthemi Indici 6
-8 grams, Herba Houttuyniae 2
-4 grams, Flos Lonicerae 6
-8 grams, Herba Patriniae 2
-4 grams, Rhizoma Paridis 2
-4 grams, Radix Salviae Miltiorrhizae 4
-6 grams, Rhizoma Osmundae 4
-6 grams, dry maxima skin 1
-1.3 gram.
Embodiment two, below are the present invention's prescription and processing technology in detail: pharmaceutical formulation of the present invention:: the Chinese crude drug of Flos Chrysanthemi Indici 7 grams, Herba Houttuyniae 3 grams, Flos Lonicerae 7 grams, Herba Patriniae 3 grams, Rhizoma Paridis 3 grams, Radix Salviae Miltiorrhizae 5 grams, Rhizoma Osmundae 5 grams, dry maxima skin 1 gram.
Processing technology of the present invention: required medicine cleaned dry, sterilization mixes pulverization, sieves, and incapsulates, and is packaged into product.
Usage: every day twice, get up morning, on an empty stomach respectively once, oral before sleeping, each about 18 grams.One month is a course of treatment.
Claims (2)
1. Chinese medicinal capsule for the treatment of hepatitis B is characterized in that it is made by following raw materials by weight proportions: Flos Chrysanthemi Indici 6
-8 grams, Herba Houttuyniae 2
-4 grams, Flos Lonicerae 6
-8 grams, Herba Patriniae 2
-4 grams, Rhizoma Paridis 2
-4 grams, Radix Salviae Miltiorrhizae 4
-6 grams, Rhizoma Osmundae 4
-6 grams, dry maxima skin 1
-1.3 gram.
2. a kind of Chinese medicinal capsule for the treatment of hepatitis B according to claim 1 is characterized in that, the best proportioning of this prescription is: Flos Chrysanthemi Indici 7 grams, Herba Houttuyniae 3 grams, Flos Lonicerae 7 grams, Herba Patriniae 3 grams, Rhizoma Paridis 3 grams, Radix Salviae Miltiorrhizae 5 grams, Rhizoma Osmundae 5 grams, dry maxima skin 1 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101072567A CN101366897A (en) | 2008-10-09 | 2008-10-09 | A Chinese medicinal capsule for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101072567A CN101366897A (en) | 2008-10-09 | 2008-10-09 | A Chinese medicinal capsule for treating hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101366897A true CN101366897A (en) | 2009-02-18 |
Family
ID=40410989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101072567A Pending CN101366897A (en) | 2008-10-09 | 2008-10-09 | A Chinese medicinal capsule for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101366897A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793889A (en) * | 2012-08-15 | 2012-11-28 | 谢安生 | Medicine treating hepatitis B |
| CN111529600A (en) * | 2020-05-16 | 2020-08-14 | 朱海真 | A Chinese medicinal composition for treating dental caries |
-
2008
- 2008-10-09 CN CNA2008101072567A patent/CN101366897A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793889A (en) * | 2012-08-15 | 2012-11-28 | 谢安生 | Medicine treating hepatitis B |
| CN111529600A (en) * | 2020-05-16 | 2020-08-14 | 朱海真 | A Chinese medicinal composition for treating dental caries |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101129593A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN103860866A (en) | Traditional Chinese medicine composition for treating acne | |
| CN101152460A (en) | Traditional Chinese medicine for treating postpartum tetanus | |
| CN101129636A (en) | Medicine for treating nasal inflammation | |
| CN101138614A (en) | Traditional Chinese Medicine for Treating Exogenous Fever | |
| CN101152426A (en) | Traditional Chinese medicine for treating periappendiceal abscess | |
| CN101062235A (en) | Chinese traditional medicine agent for treating osteomyelitis | |
| CN101757505A (en) | Traditional Chinese medicine composition for treating pulmonary abscess | |
| CN101152494A (en) | Traditional Chinese medicine for treating acute appendicitis | |
| CN101366897A (en) | A Chinese medicinal capsule for treating hepatitis B | |
| CN101015661A (en) | Medicine for treating herpes and wart | |
| CN103417877A (en) | Cancer treatment and prevention by utilization of herbal medicine | |
| CN101732478A (en) | Chinese medicament for treating constipation | |
| CN102018873A (en) | Chinese medicinal preparation for treating influenza | |
| CN104056177A (en) | Traditional Chinese medicine composition for treating otitis media | |
| CN103055055A (en) | Traditional Chinese medicine for treating skin diseases | |
| CN102343031A (en) | Chinese medicinal composition for treating osteomyelitis | |
| CN101991776A (en) | Chinese traditional medicine preparation for treating viral influenza | |
| CN101757335A (en) | Traditional Chinese medicine pill for treating chronic pneumonia | |
| CN1261130C (en) | Medicine for dispelling tinea | |
| CN101152293A (en) | Traditional Chinese medicine for treating dacryocystitis caused by up-attacking of liver wind-damp-heat | |
| CN104352649A (en) | Preparation method of traditional Chinese medicine for treating cholecystitis | |
| CN102038834A (en) | Traditional Chinese medicine preparation for preventing and treating cancers | |
| CN100393345C (en) | Oral preparation for treating gynecopathy | |
| CN101161277A (en) | Mammary gland hyperplasia wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20090218 |